Ergoteles LLC Immunovant, Inc. Transaction History

Ergoteles LLC

  • $68.2 Billion
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$3.93 - $6.37 $9,927 - $16,090
-2,526 Reduced 16.92%
12,400 $69,000
Q2 2022

Aug 12, 2022
BUY
$3.38 - $5.65 $50,449 - $84,331
14,926 New
14,926 $58,000
Q2 2021

Aug 12, 2021
SELL
$9.4 - $16.85 $139,120 - $249,380
-14,800 Closed
0 $0
Q1 2021

May 12, 2021
BUY
$13.08 - $49.6 $193,584 - $734,080
14,800 New
14,800 $237,000

Others Institutions Holding IMVT

# of Institutions
211
Shares Held
66M
Call Options Held
2.3M
Put Options Held
631K
View Full List

About Immunovant, Inc.

IMVT Quotes by TradingView
  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Ergoteles LLC Portfolio

Follow Ergoteles LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ergoteles LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email